Local application of antimycotics in mucormycosis cerebri: a case report.
A 65 year old man was found to have mucormycosis cerebri during immunosuppression after treatment of hairy cell leukaemia with 2-chlorodeoxyadenosine. Although mucormycosis cerebri has a poor prognosis, the patient survived after systemic administration of high dose amphotericin B, extensive excision of the abscess, and additional local application of amphotericin B with the help of an absorbable gelatin sponge.
Mohsenipour
I
I
Department of Neurosurgery, University of Innsbruck, Austria.
Schirmer
M
M
Frank
R
R
Geisen
F
F
Semenitz
E
E
zur Nedden
D
D
Konwalinka
G
G
D000287:Administration, Topical; D000368:Aged; D000666:Amphotericin B / Q000008:administration & dosage*; D000818:Animals; D000935:Antifungal Agents / Q000008:administration & dosage*; D001927:Brain Diseases / Q000188:drug therapy* / Q000382:microbiology*; D005780:Gelatin; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D009091:Mucormycosis / Q000188:drug therapy*; D016896:Treatment Outcome
D000935:Antifungal Agents; D000666:Amphotericin B; D005780:Gelatin